Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Revenue (2023)

Historic Revenue for Contineum Therapeutics (CTNM) over the last 1 years, with Q2 2023 value amounting to $50.0 million.

  • Contineum Therapeutics' Revenue changed N/A to $50.0 million in Q2 2023 from the same period last year, while for Mar 2024 it was $50.0 million, marking a year-over-year change of. This contributed to the annual value of $50.0 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Contineum Therapeutics reported Revenue of $50.0 million as of Q2 2023.
  • Contineum Therapeutics' 5-year Revenue high stood at $50.0 million for Q2 2023, and its period low was -$92000.0 during Q1 2023.